C5L2, a nonsignaling C5A binding protein

Biochemistry

Volumn 42, Issue 31, 2003, Pages 9406-9415

  Okinaga, Shoji ^a   Slattery, Dubhfeasa ^a   Humbles, Alison ^a   Zsengeller, Zsusanna ^a   Morteau, Olivier ^a   Kinrade, Michele Bennett ^b   Brodbeck, Robbin M ^b   Krause, James E ^b   Choe, Hye Ryun ^a   Gerard, Norma P ^a,c   Gerard, Craig ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NEUROGEN CORPORATION   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOLOGICAL MEMBRANES; CELLS; PROTEINS;

INFLAMMATORY MEDIATORS;

BIOCHEMISTRY;

ANAPHYLATOXIN; ARGININE; ARGININE DERIVATIVE; C5L2 PROTEIN; CALCIUM; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5A RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; BONE MARROW CELL; C5L2 GENE; CALCIUM TRANSPORT; CHEMOTAXIS; DNA MICROARRAY; DRY SEQUENCE; ENZYME ACTIVATION; GENE; GENE INDUCTION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; INTERNALIZATION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; BINDING SITES; BINDING, COMPETITIVE; BLOTTING, WESTERN; BONE MARROW CELLS; CALCIUM; CLONING, MOLECULAR; COMPLEMENT C5A; COMPLEMENT C5A, DES-ARGININE; GENE EXPRESSION PROFILING; GTP-BINDING PROTEINS; HUMANS; INHIBITORY CONCENTRATION 50; LIGANDS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROTEIN BINDING; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, CHEMOKINE; RECEPTORS, COMPLEMENT; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

MURINAE;

EID: 0041571471     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi034489v     Document Type: Article

References (41)

1. Gerard, N. P., and Gerard, C. (1991) The Chemotactic receptor for human C5a anaphylatoxin, Nature 349, 614-7.
2. Lambris, J. D., Reid, K. B., and Volanakis, J. E. (1999) The evolution, structure, biology, and pathophysiology of complement, Immunol. Today 20, 207-11.
3. Sahu, A., and Lambris, J. D. (2001) Structure and biology of complement protein C3, a connecting link between innate and acquired immunity, Immunol. Rev. 180, 35-48.
4. Kohl, J. (2001) Anaphylatoxins and infectious and noninfectious inflammatory diseases, Mol. Immunol. 38, 175-87.
5. Humbles, A. A., Lu, B., Nilsson, C. A., Lilly, C., Israel, E., Fujiwara, Y., Gerard, N. P., and Gerard, C. (2000) A role for the C3a anaphylatoxins receptor in the effector phase of asthma, Nature 406, 998-1001.
6. Krug, N., Tschernig, T., Erpenbeck, V. J., Hohlfeld, J. M., and Kohl, J. (2001) Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma, Am. J. Respir. Crit. Care Med. 164, 1841-3.
7. Bautsch, W., Hoymann, H. G., Zhang, Q., Meier-Wiedenbach, I., Raschke, U., Ames, R. S., Sohns, B., Flemme, N., Meyer zu Vilsendorf, A., Grove, M., Klos, A., and Kohl, J. (2000) Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma, J. Immunol. 165, 5401-5.
8. Drouin, S. M., Corry, D. B., Kildsgaard, J., and Wetsel, R. A. (2001) Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector in a murine model of pulmonary allergy, J. Immunol. 167, 4141-5.
9. Boulay, F., Mery, L., Tardif, M., Brouchon, L., and Vignais, P. (1991) Expression cloning of a receptor for C5a anaphylatoxion on differentiated HL-60 cells, Biochemistry 30, 2993-9.
10. Drouin, S. M., Kildsgaard, J., Haviland, J., Zabner, J., Jia, H. P., McCray, P. B., Jr., Tack, B. F., and Wetsel, R. A. (2001) Expression of the complement anaphylatoxion C3a and C5a receptors on bronchial epithelial and smooth muscle cells in model of sepsis and asthma, J. Immunol. 166, 2025-32.
11. Haviland, D. L., McCoy, R. L., Whitehead, W. T., Akama, H., Molmenti, E. P., Brown, A., Haviland, J. C., Parks, W. C., Perlmutter, D. H., and Wetsel, R. A. (1995) Cellular expression of the C5a anaphylatoxion receptor (C5aR): demonstration of C5aR on nonmyeloid cells of liver and lung, J. Immunol. 154, 1861-9.
12. Hopken, U. E., Lu, B., Gerard, N. P., and Gerard, C. (1996) The C5a chemoattractant receptor mediates mucosal defense to infection, Nature 383(8), 6-89.
13. Fischer, W. H., Jagels, M. A., and Hugli, T. E. (1999) Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a des Arg, J. Immunol. 162, 453-9.
14. Bhatia, M., Saluja, A. K., Singh, V. P., Frossard, J. L., Lee, H. S., Bhagat, L., Gerard, C., and Steer, M. L. (2001) Complement factor C5a exerts an antiinflammatory effect in acute pancreatitis and associated lung injury, Am. J. Physiol. Gastrointest. Liver Physiol. 280, G974-8.
15. Huber-Lang, M., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Younkin, E. M., Laudes, I. J., Reidemann, N. C., Younger, J. G., and Ward, P. A. (2001) Protective effects of anti-C5a peptide antibodies in experimental sepsis, FASEB J. 15, 568-70.
16. Gerard, N. P., Lu, B., Xiao-Ping, H., Eddy, R. L., Jr., Shows, T. B., and Gerard, C. (1993) Human chemotaxis receptor genes cluster at 19q13.3-13.4. Characterization of the human C5a receptor gene, Biochemistry 32, 1243-50.
17. Ohno, M., Hirata, T., Enomoto, M., Araki, T., Ishimaru, H., and Takahashi, T. A. (2000) A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells but not in mature dendritic cells, Mol. Immunol. 37, 407-12.
18. Farzan, M., Schnitzler, C. E., Vasilieva, N., Leung, D., Kuhn, J., Gerard, C., Gerard, N. P., and Choe, H. (2001) Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor, J. Exp. Med. 193, 1059-66.
19. Wetsel, R. A., Lemons, R. S., LeBeau, M. M., Barnum, S. R., Noack, D., and Tack, B. F. (1988) Molecular analysis of human complement component C5: localization of the structural gene to chromosome 9, Biochemistry 27, 1474-82.
20. Franke, A. E., Andrews, G. C., Stimler-Gerard, N. P., Gerard, C., and Showell, H. J. (1988) Human C5a anaphylatoxins: gene synthesis, expression, and recovery of biologically active material from Escherichia coli, Methods Enzymol. 162, 653-68.
21. DeMartino, J. A., Van Riper, G., Siciliano, S. J., Molineaux, C. J., Konteatis, Z. D., Rosen, H., and Springer, M. S. (1994) The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogues, J. Biol. Chem. 269, 14446-50.
22. Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., Gerard, C., and Sodroski, J. (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5, Nature 384, 179-83.
23. Werfel, T., Zwirner, J., Oppermann, M., Sieber, A., Begemann, G., Drommer, W., Kapp, A., and Gotze, O. (1996) CD 88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin, J. Immunol. 157, 1729-35.
24. Amatruda, T. T., III, Gerard, N. P., Gerard, C., and Simon, M. I. (1993) Specific interactions of chemoattractant factor receptors with G proteins, J. Biol. Chem. 268, 10139-44.
25. Cain, S. A., and Monk, P. N. (2002) The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg74, J. Biol. Chem. 277, 7165-9.
26. Kalant, D., Cain, S. A., Maslowska, M., Sniderman, A. D., Cianflone, K., and Monk, P. N. (2003) The chemoattractant receptor-like protein, C5L2, binds C3a des Arg77/acylation stimulation protein, J. Biol. Chem. 278, 11123-9.
27. McDonald, P. H., Chow, C. W., Miller, W. E., Laporte, S. A., Field, M. E., Lin, F. T., Davis, R. J., and Lefkowitz, R. J. (2000) β-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3, Science 290, 1574-7.
28. Mhaouty-Kodja, S., Barak, L. S., Scheer, A., Abuin, L., Diviani, D., Caron, M. G., and Cotecchia, S. (1999) Constitutively active α-1b adrenergic receptor mutants display different phosphorylation and internalization features, Mol. Pharmacol. 55, 339-47.
29. Okada, T., and Palczewski, K. (2001) Crystal structure of rhodopsin: implications for vision and beyond, Curr. Opin. Struct. Biol. 11, 420-6.
30. Kolakowski, L. F., Jr., Lu, B., Gerard, C., and Gerard, N. P. (1995) Probing the "message: address" sites for chemoattractant binding to the C5a receptor. Mutagenesis of hydrophilic and proline residues within the transmembrane sequences, J. Biol. Chem. 270, 18077-82.
31. Farzan, M., Choe, H., Martin, K. A., Sun, Y., Sidelko, M., Mackay, C. R., Gerard, N. P., Sodroski, J., and Gerard, C. (1997) HIV-1 entry and macrophage inflammatory protein-1β-mediated signaling are independent functions of the chemokine receptor CCR5, J. Biol. Chem. 272, 6854-7.
32. Gerard, N. P., Hodges, M. K., Drazen, J. M., Weller, P. F., and Gerard, C. (1989) Characterization of a receptor for C5a anaphylatoxin on human eosinophils, J. Biol. Chem. 264, 1760-6.
33. Paczkowski, N. J., Finch, A. M., Whitmore, J. B., Short, A. J., Wong, A. K., Monk, P. N., Cain, S. A., Fairlie, D. P., and Taylor, S. M. (1999) Pharmacological characterization of antagonists of the C5a receptor, Br. J. Pharmacol. 128, 1461-6.
34. Eglite, S., Pluss, K., and Dahinden, C. A. (2000) Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils, J. Immunol. 165, 2183-9.
35. Campbell, W., Okada, N., and Okada, H. (2001) Carboxypeptidase R is inactivator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis, Immunol. Rev. 180, 162-7.
36. Pogo, A. O., and Chaudhuri, A. (2000) The Duffy protein: a malarial and chemokine receptor, Semin. Hematol. 37, 122-9.
37. Nibbs, J. R., Wylie, S. M., and Yang, J. (1997) Cloning and characterization of a novel promiscuous human β-chemokine receptor D6, J. Biol. Chem. 272, 32078-83.
38. Schweickart, V. L., Epp, A., Raport, C. J., and Gray, P. W. (2001) CCR11 is a functional receptor for the monocyte chemoaattractant protein family of chemokines, J. Biol. Chem. 276, 856-63.
39. Gosling, J., Dairaghi, D. J., Wang, Y., Hanley, M., Talbot, D., Miao, Z., and Schall, T. J. (2000) Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cellactive chemokines including ELC, SLC, and TECK, J. Immunol. 164, 2851-6.
40. Nibbs, R. J., Kriehuber, E., Ponath, P. D., Parent, D., Qin, S., Campbell, J. D., Henderson, A., Kerjaschki, D., Maurer, D., Graham, G. J., and Rot, A. (2001) The β-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors, Am. J. Pathol. 158, 867-77.
41. Wong, L.-M., Myers, S. J., Tsou, C.-L., Gosling, J., Arai, H., and Charo, I. F. (1997) Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking, J. Biol. Chem. 272, 1038-45.